We are using cookies to implement functions like login, shopping cart or language selection for this website. Furthermore we use Google Analytics to create anonymized statistical reports of the usage which creates Cookies too. You will find more information in our privacy policy.
OK, I agree I do not want Google Analytics-Cookies
The International Journal of Oral & Maxillofacial Implants
Login:
username:

password:

Plattform:

Forgotten password?

Registration

Int J Oral Maxillofac Implants 29 (2014), No. 5     6. Oct. 2014
Int J Oral Maxillofac Implants 29 (2014), No. 5  (06.10.2014)

Page 1198-1203, doi:10.11607/jomi.3543, PubMed:25216148


Recombinant Human Bone Morphogenetic Protein 2 in Augmentation Procedures: Case Reports
Luiz, Jaques / Padovan, Luis Eduardo Marques / Claudino, Marcela
To successfully rehabilitate edentulous patients using endosseous implants, there must be enough available bone. Several techniques have been proposed for augmentation of sites with insufficient bone volume. Although autogenous bone has long been considered the gold standard for such procedures, the limited availability of graft material and a high morbidity rate are potential disadvantages of this type of graft. An alternative is to use recombinant human bone morphogenetic protein 2 (rhBMP-2), which is able to support bone regeneration in the oral environment. These cases demonstrate the applicability of rhBMP-2 in maxillary sinus elevation and augmentation procedures in the maxilla to enable dental implant placement. The use of rhBMP-2 in alveolar augmentation procedures had several clinical benefits for these patients.

Keywords: bone regeneration, bone transplantation, oral surgery, recombinant human bone morphogenetic protein 2